HOME >> BIOLOGY >> NEWS
Vaccine prevents prion disease in mice

BOSTON An oral vaccine can prevent mice from developing a brain disease similar to mad cow disease, according to research that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 May 5, 2007. Prion diseases, which include scrapie, mad cow disease, and chronic wasting disease, are fatal and there is no treatment or cure.

The disease spreads when an animal eats the body parts of other animals contaminated with prions. The disease causes dementia and abnormal limb movements.

Prion is a protein that is also an infectious agent. The proteins are so similar to proteins found normally that the immune system does not fight them off. To develop a vaccine that would stimulate the mice's immune system, researchers attached prion proteins to a genetically modified strain of Salmonella.

For the study, the mice were orally vaccinated with a safe, attenuated Salmonella strain, which expressed the prion protein. Then they were divided into two groups those who had high levels of antibodies in their blood and thus responded well to the vaccine and those with low levels of antibodies.

The mice with high levels of antibodies had no symptoms of the disease after 400 days. The mice with low levels of antibodies also had a significant delay in the onset of the disease. It normally takes 120 days for mice that have not been vaccinated to develop the disease.

"These are promising findings," said study author Thomas Wisniewski, MD, of NYU School of Medicine in New York, and a member of the American Academy of Neurology. "We are now in the process of redesigning the vaccine so it can be used on deer and cattle."

Wisniewski said much more work is needed before the vaccine could be considered for humans. "The human version of prion disease usually occurs spontaneously and only rarely because of eating contaminated meat," he said. "But if, for example, a more significant outbreak
'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
3-May-2007


Page: 1 2

Related biology news :

1. Vaccine trials inject hope into koalas future
2. Vaccine hope for malaria
3. Vaccine hope for sufferers of potentially fatal stomach bug
4. Vaccine to cope with viral diversity in HIV
5. PATH Malaria Vaccine Initiative announces partnership to develop novel malaria vaccine
6. U of S Vaccine and Infectious Disease Organization team discovers key step in flu virus replication
7. Vaccine-producing plant-factories
8. HPV Vaccine: Whats next
9. Vaccine shown effective against chancroid
10. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
11. Vaccine provides 100 percent protection against avian flu virus in animal study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2020)... OMAHA, Neb. (PRWEB) , ... February 28, 2020 , ... ... win the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial ... is a finalist for the Best Clinical Trial Network award. These nominations were the ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... Rebound PRP™ and Rebound PRF® devices are now available to veterinary practices ... regenerative medical devices, that will provide the most affordable, easiest to use, ...
(Date:2/28/2020)... ... February 27, 2020 , ... An upcoming ... treatment solutions for maladies, such as Inflammatory Bowel Disease (IBD), specifically Crohn’s Disease ... will focus on a novel platform developed by Deka Biosciences, Inc. (Deka Biosciences), ...
Breaking Biology News(10 mins):
(Date:2/28/2020)... DIEGO (PRWEB) , ... February 26, 2020 , ... ... HS7 system combines a high-speed camera with a dedicated controller, thus simplifying ... frames per second, the HS7 is the first of Fastec Imaging’s new HS ...
(Date:2/26/2020)... ... February 25, 2020 , ... Continuing its leading research ... results of its safety assessment on the biotechnologically produced 3-Fucolsyllactose (3-FL) HMO. ... These complex carbohydrates are indigestible and therefore function as a prebiotic by promoting ...
(Date:2/21/2020)... ... February 20, 2020 , ... In a free ... speakers from Synteract including Lisa Dilworth, BS, MS, Vice President Rare, Orphan ... challenges, with feasible strategies and solutions to support patients, sites and sponsors. , When ...
(Date:2/21/2020)... ... February 20, 2020 , ... ... complex, efficient and elegant chemistry. Humans have been increasingly successful in innovating ... , Through rapidly evolving technologies and strategies for modern molecular biology (e.g., ...
Breaking Biology Technology:
Cached News: